Clinical Endoscopy

  • 제55권3호
  • /
  • Pages.365-366
  • /
  • 2022
  • /
  • 2234-2400(pISSN)
  • /
  • 2234-2443(eISSN)
대한소화기내시경학회 (The Korean Society of Gastrointestinal Endoscopy)
권호 표지
DOI QR코드

DOI QR Code

Lessons learned in clinical epidemiology of esophageal adenocarcinoma

  • Hye Kyung Jung (Department of Internal Medicine, College of Medicine, Ewha Womans University)
  • 투고 : 2022.03.28
  • 심사 : 2022.04.18
  • 발행 : 2022.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Arnold M, Ferlay J, van Berge Henegouwen MI, et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 2020;69:1564-1571.  https://doi.org/10.1136/gutjnl-2020-321600
  2. Launoy G, Bossard N, Castro C, et al. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev 2017;26:S24-S31.  https://doi.org/10.1097/CEJ.0000000000000308
  3. Arnold M, Laversanne M, Brown LM, et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol 2017;112:1247-1255.  https://doi.org/10.1038/ajg.2017.155
  4. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol Off J Eur Soc Med Oncol 2012;23:3155-3162.  https://doi.org/10.1093/annonc/mds181
  5. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.  https://doi.org/10.1056/NEJM199903183401101
  6. Pandeya N, Olsen CM, Whiteman DC. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol 2013;37:579-584.  https://doi.org/10.1016/j.canep.2013.05.011
  7. Hang TP, Spiritos Z, Gamboa AM. Epidemiology of early esophageal adenocarcinoma. Clin Endosc 2022;55:372-380.  https://doi.org/10.5946/ce.2021.152
  8. National Institutes of Health. SEER*Stat Software (version 8.4.0) [Internet]. Maryland: National Institutes of Health; c2022 [cited 2022 Apr 22]. Available from: https://seer.cancer.gov/seerstat/index.html. 
  9. Paris S, Ekeanyanwu R, Jiang Y, et al. Obesity and its effects on the esophageal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2021;321:G335-G343.  https://doi.org/10.1152/ajpgi.00199.2021
  10. Sikkema M, de Jonge PJ, Steyerberg EW, et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol 2010;8:235-244; quiz e32.  https://doi.org/10.1016/j.cgh.2009.10.010
  11. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics 2015;33:673-689.  https://doi.org/10.1007/s40273-014-0243-x
  12. Jung HK, Tae CH, Lee HA, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PloS One 2020;15:e0231456. 
  13. Shaheen NJ, Falk GW, Iyer PG, et al, American College of Gastroenterology. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol 2016;111:30-50; quiz 51. https://doi.org/10.1038/ajg.2015.322